par Socié, Gérard;Gard, Philippe;Medeghri, Zakaria;Lehert, Philippe;Lai, Chinglin;Corn, Tim;Vernant, Jean Paul;Vigouroux, Stéphane;Yakoub-Agha, Ibrahim;Bay, Jacques Olivier;Fürst, Sabine;Bilger, Karin;Suarez, Felipe;Michallet, Mauricette;Bron, Dominique
Référence Blood, 129, 5, page (643-649)
Publication Publié, 2017-02
Référence Blood, 129, 5, page (643-649)
Publication Publié, 2017-02
Article révisé par les pairs
Titre: |
|
Auteur: | Socié, Gérard; Gard, Philippe; Medeghri, Zakaria; Lehert, Philippe; Lai, Chinglin; Corn, Tim; Vernant, Jean Paul; Vigouroux, Stéphane; Yakoub-Agha, Ibrahim; Bay, Jacques Olivier; Fürst, Sabine; Bilger, Karin; Suarez, Felipe; Michallet, Mauricette; Bron, Dominique |
Informations sur la publication: | Blood, 129, 5, page (643-649) |
Statut de publication: | Publié, 2017-02 |
Sujet CREF: | Hématologie |
MeSH keywords: | Acute Disease |
Adult | |
Antibodies, Monoclonal -- adverse effects -- therapeutic use | |
Antilymphocyte Serum -- adverse effects -- therapeutic use | |
Drug Resistance | |
Female | |
Graft vs Host Disease -- drug therapy | |
Humans | |
Immunosuppressive Agents -- adverse effects -- therapeutic use | |
Male | |
Middle Aged | |
Proportional Hazards Models | |
Steroids -- therapeutic use | |
Survival Analysis | |
Treatment Outcome | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0006-4971 |
info:doi/10.1182/blood-2016-09-738625 | |
info:pii/blood-2016-09-738625 | |
info:scp/85014848812 | |
info:pmid/27899357 |